Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium.
Fast solution switching techniques in single myofibrils offer the opportunity to dissect and directly examine the sarcomeric mechanisms responsible for force generation and relaxation. The feasibility of this approach is tested here in human cardiac myofibrils isolated from small samples of atrial and ventricular tissue. At sarcomere lengths between 2.0 and 2.3 mum, resting tensions were significantly higher in ventricular than in atrial myofibrils. The rate constant of active tension generation after maximal Ca(2+) activation (k (ACT)) was markedly faster in atrial than in ventricular myofibrils. In both myofibril types k (ACT) was the same as the rate of tension redevelopment after mechanical perturbations and decreased significantly by decreasing [Ca(2+)] in the activating solution. Upon sudden Ca(2+) removal, active tension fully relaxed. Relaxation kinetics were (1) much faster in atrial than in ventricular myofibrils, (2) unaffected by bepridil, a drug that increases the affinity of troponin for Ca(2+), and (3) strongly accelerated by small increases in inorganic phosphate concentration. The results indicate that myofibril tension activation and relaxation rates reflect apparent cross-bridge kinetics and their Ca(2+) regulation rather than the rates at which thin filaments are switched on or off by Ca(2+) binding or removal. Myofibrils from human hearts retain intact mechanisms for contraction regulation and tension generation and represent a viable experimental model to investigate function and dysfunction of human cardiac sarcomeres.
Piroddi
Nicoletta
N
Centro Interuniversitario di Medicina Molecolare e Biofisica Applicata, Florence, Italy.
Belus
Alexandra
A
Scellini
Beatrice
B
Tesi
Chiara
C
Giunti
Gabriele
G
Cerbai
Elisabetta
E
Mugelli
Alessandro
A
Poggesi
Corrado
C
D000328:Adult; D000368:Aged; D002118:Calcium / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005240:Feasibility Studies; D005260:Female; D006321:Heart / Q000502:physiology*; D006325:Heart Atria; D006352:Heart Ventricles; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000502:physiology*; D009206:Myocardium / Q000378:metabolism; D009210:Myofibrils / Q000502:physiology*; D010710:Phosphates / Q000378:metabolism; D010812:Physical Stimulation; D011930:Reaction Time / Q000187:drug effects; D012518:Sarcomeres / Q000502:physiology; D012996:Solutions
D010710:Phosphates; D012996:Solutions; D002118:Calcium